Sunil Verma: Francisco J Peña’s project will focus on developing AI-based tools for precision medicine in cancer
Sunil Verma, SVP, Global Head of Oncology at AstraZeneca, shared a post by on LinkedIn:
“Many congratulations to Francisco J Peña who has been selected from a pool of more than 100 candidates for a Precision Medicine Postdoctoral role supported by AstraZeneca at the Karolinska Institutet.
His project will focus on developing AI-based tools for precision medicine in cancer, using diagnostic and clinical data to enhance patient outcomes. Congratulations Francisco and big thanks to the incredible leads including Benedikte Thunes Akre who are driving this program and collaboration forward.”
Quoting
“𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗔𝗜: 𝗔 𝗣𝗶𝗼𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗡𝗼𝗿𝗱𝗶𝗰 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻
Exciting News! Our postdoctoral partnership with AstraZeneca is officially underway. This collaboration, involving Karolinska Institutet and Oslo University Hospital, is set to improve lung and breast cancer care through AI-driven precision diagnostics.
We’re thrilled to announce that Francisco J. Peña has been selected and started as the KI-postdoc from an impressive global pool of over 100+ candidates across KI and OUS. His project focuses on developing AI-based tools for precision medicine in cancer, utilizing existing diagnostic and clinical data to enhance patient outcomes.
From the same pool of talents, we eagerly awaiting the Oslo University Hospital announcement of their candidate, so that our projects can learn from each other and continuously improve. Stay tuned as we share our journey and breakthroughs in this exciting field!
This partnership is a groundbreaking example of public-private cooperation across the Nordic region, designed to spur innovation and empower early career scientists. It’s all about transforming research into real-world clinical applications, directly benefiting patient care.”
Source: Sunil Verma/LinkedIn and
